Article
Polygenic embryo screening: four clinical considerations warrant further attention.
Human reproduction (Oxford, England) - 30 Jun 2022
Pereira S, Carmi S, Altarescu G, Austin J, Barlevy D, Hershlag A, Juengst E, Kostick-Quenet K, Kovanci E, Lathi R B, Mukherjee M, Van den Veyver I, Zuk O, Lázaro-Muñoz G, Lencz T
Abstract excerpt
Recent advances in developing polygenic scores have made it possible to screen embryos for common, complex conditions and traits. Polygenic embryo screening (PES) is currently offered commercially, and though there has been much recent media and academic coverage, reproductive specialists' points of view have not yet been prominent in these discussions. We convened a roundtable of multidisciplinary experts,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
